The Mullings Group Companies is west coast bound for the MedTech Innovator Summit in Mountain View, CA. Dragonfly - A TMG Company is proud to be the Official Media Partner for the event. In partnership with Paul Grand and the MTI team, we will be capturing the stories and full experience of MedTech Innovator. Holly Scott & Nicole Ager will be leading a breakout session covering Attention & Awareness as you build a buzz around your company to attract talent, investment, and value. See you in Cali!
The Mullings Group’s Post
More Relevant Posts
-
My calendar’s next red circle is September 16th. ⭕️ That’s when we’re bringing hundreds of Medtech leaders together in Portugal. There aren’t enough conversations highlighting the role that so many founders and CEOs outside of the US are playing in our industry. Let’s change that! Which European founders and CEOs are you seeing advance innovation in Medtech?
To view or add a comment, sign in
-
My calendar’s next red circle is for September 16th. ⭕️ That’s when we’re bringing hundreds of Medtech leaders together next in Portugal. After listening in on the panel about Israel’s role in global Medtech innovation, it’s clear that there aren’t enough conversations highlighting the role that so many founders and CEOs outside of the US are playing in our industry. Let’s change that. Which European founders and CEOs are you seeing advance innovation in Medtech?
To view or add a comment, sign in
-
When it comes to strategizing and networking, your time is valuable. Why navigate a vast sea when you can thrive in a focused environment? At MedTech Strategist's Innovation Summit, you won’t struggle for attention while pursuing your goals. This is the MedTech industry's premier intimate conference, designed to offer you meaningful connections and a comfortable space to learn and engage. Gain the competitive edge you need. Reach new heights at the Summit of Innovation: https://bit.ly/3ygP9vr
To view or add a comment, sign in
-
MedTech Innovator | Expert in International Expansion & Emerging Markets | Connecting Top Freelance Talent with Global Opportunities
If you lead a company that is poised for international growth, I invite you to have a look at our experience with one of our customers. We've created a case study that details the strategic steps we took, the obstacles we overcame, and the significant outcomes we achieved. Taking a company into new territories is no easy task. To overcome unique challenges, a thorough understanding of local dynamics is required, as is a strong network and a tailored approach. Take this tour with us. #GlobalExpansion #MarketEntry #MedTech #NavixTalents #BusinessLeadership #StrategicInsights
We're excited to share with you a case study highlighting our collaboration with one of our Partners. This MedTech start-up successfully launched its product in emerging markets, thanks to our tailored expert solutions. 👀 Swipe through our carousel to see how strategic planning and the right partnerships can lead to remarkable outcomes in market entry. 🚀 Ready to explore what NavixTalents can do for your business? Let’s connect and make your market expansion goals a reality! #NavixTalents #MedTech #MarketEntry #SuccessStory #InnovationInHealthcare
To view or add a comment, sign in
-
In the ever-evolving MedTech industry, speed and efficiency in scaling operations can make or break success. At NavixTalents, we specialise in empowering businesses to scale rapidly without compromising quality. Discover how our innovative approach has transformed challenges into growth opportunities for our partners. Swipe through our carousel to explore a real-life business case where NavixTalents facilitated rapid scaling for a leading MedTech company, helping them expand operations seamlessly across new markets. 👉 Learn how our tailored solutions can do the same for your business. Let's drive growth together! #MedTech #RapidScaling #BusinessGrowth #NavixTalents #InnovationInHealthcare
To view or add a comment, sign in
-
Why is innovation important for you? 🌟 Listen to our experts; Dr Guenther Dobrauz-Saldapenna, Elisabeth Drzaic-Lang, Uli Haist, Francesco Pagano answer that simple yet challenging question. 🚀 Sign up on our platform where innovation is most important to us: https://lnkd.in/et5WqtXP #Innovation #ExpertTalks #JoinUs #InnovatorsSerendipityAcademy
To view or add a comment, sign in
-
Jennifer Allison, Mark Gillespie, and I (rob@woxi.io) can't wait to see clients and partners at Quirk's Media in Dallas a week from today! We want to learn about how you make innovation decisions and to see if Woxi can help make better innovation journeys and better innovation outcomes, in your organization! #insighttoimpact #insights #innovation #quirksdallas #predictiveanalytics
To view or add a comment, sign in
-
Time's ticking, and #InnovationSanDiego is right around the corner. Imagine being in the room with leaders who are reshaping the future of medtech—like Todd Brinton, MD from Edwards Lifesciences—sharing insights that could change the game for your business. This isn't just another conference. It's a launchpad for connections that could unlock your next breakthrough, with emerging #medtech innovators pitching their bold ideas and exclusive access to breakout meetings designed for real partnerships. Don't miss your chance to be part of it all. Will you be there? 👉 Start your journey to climb the summit: https://bit.ly/3ygP9vr
To view or add a comment, sign in
-
Managing Director & Health Economist - Adding Openness & Transparency to Decision-Making within the Healthcare System.
Abbas: How should I start the post? My wife: You always say 'a big shoutout' ... A huge THANK YOU to the Technology Investment Network & Medtech-iQ Aotearoa for hosting tonight's Healthtech Report 2024 Launch. It's clear how much work has gone into this ...with over 1200+ surveys and questionnaires across the health sector - Alex, Lucy and Greg, you should all be very proud! Also - thanks to the diverse panel (Natalia, Kate, Ehsan, Aisling and Peter) for their insights and comments...some of which are summarised below. Innovation vs. Infrastructure: Growing number of spin-outs; collaboration is key, but infrastructure and funding remain challenges. Global Opportunities: Interest in the U.S. and European markets; faster adoption rates abroad, but NZ’s small size offers unique clinical trial advantages. Regulatory & IP Strategy: Early clarity on regulatory and IP strategies is crucial; success depends on more than just the best technology. Market Strategy: Scalability, meeting unmet needs, and strategic alignment with clinicians, regulators, and VCs are essential for market success. And lastly, thank you to Diana Siew and the wider team (Elena, Sacha, Kate).
To view or add a comment, sign in
-
After a productive networking break in the Great Room Foyer, we now have the “Medtech by the Numbers” Panel Session, moderated by Jennifer McMahon, Partner at Seroba.: • Inga D. Deakin, Principal, Molten Ventures • Megan MacDonagh, Vice President, SV Health Investors • Anne Portwich, Partner, EQT Life Sciences • Sylvain Sachot, Partner, Asabys Partners 2023 life science investment went down across the board, in biotech and medtech equally, but in diagnostics and healthtech to a greater degree. A panel of European VCs discusses what’s in store for 2024. The number of up-rounds is down, which is a negative for VC firms supporting early-stage companies. The situation needs to change in order to reward early investment, the lifeblood of medtech innovation. We are seeing a lot of structured deals, option deals with many milestones. It does look good when a strategic is interested in a company, and it provides a path for exit. But it is a two-sided sword. Remain informed on new articles, conference updates and more with our helpful medtech community newsletter. Subscribe here: https://bit.ly/42KHJKI
To view or add a comment, sign in
99,344 followers
Vice President & Partner at The Mullings Group | Global Medical Device & Life Sciences | Executive Search-Building Companies and Careers
3moGlad to have our west coast partner Mike Moore with us as well!